Diabetes Mellitus is a group of metabolic disorders characterised by chronically elevated blood glucose because insulin is absent, insufficient, ineffective, or some combination of these mechanisms. Insulin is a hormone produced by pancreatic beta cells that facilitates glucose uptake and storage and suppresses excessive glucose production by the liver. When glucose regulation is impaired, persistent hyperglycaemia develops and can progressively affect blood vessels, nerves, kidneys, eyes and other tissues. The term encompasses several biologically different disorders rather than representing one single disease mechanism. The principal forms are Type 1 Diabetes and Type 2 Diabetes, while gestational diabetes and several less common forms arise from other causes.
The defining physiological problem varies between forms. Type 1 Diabetes generally results from autoimmune destruction of pancreatic beta cells, producing severe or complete insulin deficiency. Type 2 Diabetes usually develops through a combination of insulin resistance, compensatory pancreatic insulin production and progressive beta-cell dysfunction. Other forms can result from particular genetic defects, pancreatic diseases, endocrine disorders, certain medicines or other recognised causes. Consequently, diabetes classification cannot always be established from a single blood glucose measurement, and the patient's age, symptoms, treatment history, body characteristics, family history and laboratory findings may all contribute to classification.
Diagnosis is based on evidence of abnormal glucose regulation using established laboratory criteria. Common approaches include measurement of glycated haemoglobin, fasting plasma glucose, a glucose tolerance test, or a suitably interpreted random plasma glucose measurement when characteristic symptoms are present. Glycated haemoglobin reflects average glycaemic exposure over approximately the preceding two to three months because glucose becomes attached to haemoglobin during the lifespan of red blood cells. Different tests answer slightly different questions, and conditions affecting red-cell turnover or haemoglobin can interfere with glycated haemoglobin interpretation. A diagnostic result therefore needs appropriate clinical context and, when necessary, confirmation according to applicable clinical guidance.
Symptoms of significant hyperglycaemia can include increased thirst, frequent urination, tiredness, blurred vision and unintended weight loss, although some people have few or no noticeable symptoms for a substantial period. Severe metabolic disturbance can produce acute emergencies, including diabetic ketoacidosis or hyperosmolar hyperglycaemic states, while prolonged hyperglycaemia contributes to chronic complications. Long-term effects can include cardiovascular disease, kidney disease, retinal damage, peripheral nerve damage and problems affecting the feet. The relationship between glucose exposure and complications is influenced by many factors, including blood pressure, lipid levels, smoking, kidney function, duration of disease and other individual characteristics.
Management is multidimensional rather than consisting solely of lowering a glucose measurement. Depending on the form and circumstances, treatment can involve insulin, glucose-lowering medicines, nutritional management, physical activity, weight management where appropriate, monitoring of glucose and attention to cardiovascular and kidney risk factors. People receiving treatment may monitor glucose using finger-prick testing or continuous glucose monitoring, with the method depending on the treatment regimen and clinical circumstances. Targets are individualised because excessively aggressive glucose lowering can cause hypoglycaemia, particularly in people using insulin or certain medicines. Treatment therefore balances reduction of harmful hyperglycaemia against avoidance of treatment-related complications.
Prevention and risk reduction differ according to the type of diabetes. Type 1 Diabetes is not currently preventable through ordinary lifestyle measures, whereas many cases of Type 2 Diabetes are associated with modifiable and non-modifiable risk factors, including family history, age, body composition, physical inactivity and previous abnormal glucose regulation. Prevention strategies for Type 2 Diabetes can include regular physical activity, appropriate dietary patterns, weight reduction when clinically appropriate and management of cardiovascular risk factors. Screening can identify elevated glucose before symptoms develop, creating an opportunity for risk reduction and earlier intervention.
A major misconception is that Diabetes Mellitus simply means consuming too much sugar or that all forms can be reversed through diet. Diabetes is a disorder of glucose regulation involving endocrine, metabolic, genetic, immunological and environmental factors, and its different forms have substantially different causes. Another misconception is that the absence of symptoms means that glucose levels are harmless. Some complications develop gradually and may be clinically silent until significant damage has occurred, which is why assessment of eyes, kidneys, cardiovascular risk and neurological or foot health can form part of ongoing care.
Diabetes Mellitus is important not only as an individual metabolic disorder but also as a major long-term health condition requiring coordinated monitoring and prevention of complications. Understanding its terminology requires distinguishing diagnosis from classification, glucose measurement from overall disease control, and treatment from complication prevention. The disease also intersects with nutrition, endocrinology, cardiovascular medicine, nephrology, ophthalmology, neurology and genetics. Its biological diversity explains why management must be tailored rather than reduced to a universal diet, medication or glucose target.
